Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetes

類似資料

• Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes
  著者:: Baker, D J, 等
  出版事項: (2014)
• The APOE(∗)3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis
  著者:: Pouwer, Marianne G., 等
  出版事項: (2019)
• Production of a mouse strain with impaired glucose tolerance by systemic heterozygous knockout of the glucokinase gene and its feasibility as a prediabetes model
  著者:: SAITO, Mikako, 等
  出版事項: (2015)
• Hyperglycemia Induced by Glucokinase Deficiency Accelerates Atherosclerosis Development and Impairs Lesion Regression in Combined Heterozygous Glucokinase and the Apolipoprotein E-Knockout Mice
  著者:: Adingupu, Damilola D., 等
  出版事項: (2016)
• Characterization of the gene expression profile of heterozygous liver-specific glucokinase knockout mice at a young age
  著者:: Guo, Tingting, 等
  出版事項: (2012)